glucagon has been researched along with dihydroergotamine in 5 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (dihydroergotamine) | Trials (dihydroergotamine) | Recent Studies (post-2010) (dihydroergotamine) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 1,450 | 241 | 116 |
Protein | Taxonomy | glucagon (IC50) | dihydroergotamine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.09 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 3.9996 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.001 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.0089 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0039 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.01 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0007 | |
D(1A) dopamine receptor | Homo sapiens (human) | 2.395 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.029 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.008 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.09 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0007 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.0053 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0068 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.0032 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 2.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnold, A; Butcher, FR; Fain, JN; Pointer, RH; Tolbert, ME | 1 |
Butcher, FR; Fain, JN; Pointer, RH | 1 |
Chan, PS; Ellis, S; Mühlbachová, E | 1 |
Allan, EH; Leach, RP; Titheradge, MA | 1 |
Hirszel, P; Maher, JF | 1 |
5 other study(ies) available for glucagon and dihydroergotamine
Article | Year |
---|---|
Cyclic nucleotides and gluconeogenesis by rat liver cells.
Topics: Animals; Carbachol; Catecholamines; Cyclic AMP; Cyclic GMP; Depression, Chemical; Dihydroergotamine; Epinephrine; Glucagon; Gluconeogenesis; In Vitro Techniques; Isoproterenol; Lactates; Liver; Liver Glycogen; Phenformin; Propranolol; Pyruvates; Rats; Tetracaine | 1975 |
Studies on the role of cyclic guanosine 3':5'-monophosphate and extracellular Ca2+ in the regulation of glycogenolysis in rat liver cells.
Topics: Adenosine Triphosphate; Adenylyl Cyclases; Animals; Atropine; Calcimycin; Calcium; Carbachol; Cyclic AMP; Cyclic GMP; Dihydroergotamine; Epinephrine; Female; Glucagon; Glucose; In Vitro Techniques; Insulin; Isoproterenol; Liver; Liver Glycogen; Phenoxybenzamine; Propranolol; Rats | 1976 |
Differences in dihydroergotamine antagonism of glucose release by catecholamines, glucagon and adenosine 3',5'-monophosphate in rabbit liver slices.
Topics: Animals; Catecholamines; Cyclic AMP; Dihydroergotamine; Female; Glucagon; Glucose; In Vitro Techniques; Liver; Male; Rabbits | 1978 |
The stimulation of glycogenolysis in isolated hepatocytes by opioid peptides.
Topics: Angiotensin II; Animals; Calcium; Dihydroergotamine; Enkephalin, Leucine; Enkephalin, Methionine; Epinephrine; Glucagon; In Vitro Techniques; Lactates; Lactic Acid; Liver; Liver Glycogen; Male; Propranolol; Rats; Rats, Inbred Strains | 1985 |
Learning peritoneal physiology by pharmacological manipulation.
Topics: Animals; Biological Transport; Cytochalasin D; Dihydroergotamine; Glucagon; Histamine; Humans; Peritoneal Dialysis; Peritoneum; Regional Blood Flow; Secretin | 1993 |